Stock listing
Pyxis Oncology, Inc.
Selected listing: PYXS · NASDAQ · USD · US
Pyxis Oncology, Inc. (NASDAQ:PYXS), Health Technology. Latest release Oct 2, 2026: Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering.
- Ticker
- NASDAQ:PYXS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Pyxis Oncology, Inc.
The company focuses on developing innovative cancer therapies. Its mission is to advance treatment options for patients with challenging cancers through its proprietary technology.
Latest news from Pyxis Oncology, Inc.
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
October 2, 2026
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
September 30, 2026
Pyxis Oncology Announces Proposed Public Offering
September 29, 2026
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
September 9, 2026
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
September 8, 2026
Research Pyxis Oncology, Inc.
Pyxis Oncology, Inc. company profile
View the public company page for Pyxis Oncology, Inc. on 6ix.
Pyxis Oncology, Inc. news
Read company news and market updates connected to Pyxis Oncology, Inc..
Pyxis Oncology, Inc. investor events
Find investor webinars, events, and replay context for Pyxis Oncology, Inc..